头颈癌患者治疗前认知功能与生活质量的关联
该病例系列在治疗前评估83例头颈癌患者,55%(46例)存在认知功能障碍。抑郁症状数量与延迟回忆受损及生活质量各领域相关,延迟回忆受损与整体及情绪、功能健康领域生活质量较低相关。
要点
- 头颈癌患者治疗前认知功能障碍常见,本组占55%。
- 延迟回忆受损与整体及情绪、功能健康领域生活质量较低相关。
- 建议将认知筛查与生活质量评估纳入治疗前评估。
核心结论
- 头颈癌患者认知功能障碍常见,且与生活质量及心理社会变量相关,结果支持将认知筛查和生活质量评估纳入治疗前评估。
研究设计与样本
- 纳入83例确诊头颈癌并接受临床健康心理学家和言语语言病理学家治疗前评估的患者。
- 治疗前评估使用蒙特利尔认知评估和癌症治疗功能评估-头颈版第4版,并进行半结构化访谈收集精神症状、社会支持和物质使用数据。
主要发现
- 83例患者中64例(77%)为男性,平均年龄59.54岁(95%CI,57.23-61.73)。
- 治疗前55%(n=46)存在认知功能障碍。
- 抑郁症状数量(平均2.43个症状,95%CI,2.06-2.89)与延迟回忆受损(r=−0.28;95%CI,−0.47至−0.07)及所有生活质量领域相关。
- 延迟回忆认知受损与整体生活质量及情绪、功能健康领域生活质量较低相关。
- 当前苯二氮䓬类使用、重度饮酒史、当前及既往烟草使用也与特定领域生活质量较低相关。
临床怎么用
- 对头颈癌患者治疗前可考虑开展认知筛查和生活质量评估,并关注抑郁症状与物质使用等心理社会因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: There is a dearth of research examining the associations between cognitive function and quality of life (QoL) in patients with head and neck cancer (HNC), despite much research examining QoL and some research examining cognitive function in this population. OBJECTIVE: To identify the associations between cognitive functioning and QoL in patients prior to treatment for HNC within a multidisciplinary care team. DESIGN, SETTING, AND PARTICIPANTS: Case series with planned data collection of cognitive function, QoL, and psychosocial variables at an urban Midwest academic medical center including 83 patients with a diagnosis of HNC between August 2015 and December 2016 who underwent a pretreatment assessment with a clinical health psychologist and a speech and language pathologist. MAIN OUTCOMES AND MEASURES: At pretreatment assessment, the Montreal Cognitive Assessment and Functional Assessment of Cancer Therapy–Head & Neck, version 4, were administered along with a semistructured interview to gather data on psychiatric symptoms, social support, and substance use. Patient demographic, clinical, and psychosocial variables were extracted via medical record review. RESULTS: Of 83 patients (64 [77%] male; mean age, 59.54 [95% CI, 57.23-61.73] years), cognitive impairment was identified in 55% (n = 46) at pretreatment. Number of depressive symptoms (mean, 2.43 [95% CI, 2.06-2.89] symptoms) was associated with impairments in delayed recall (r = −0.28; 95% CI, −0.47 to −0.07) and all domains of QoL. Cognitive impairment in delayed recall was associated with lower QoL in both overall QoL and the domains of emotional and functional well-being. Current benzodiazepine use, history of heavy alcohol use, and current and past tobacco use were also associated with lower QoL in specific domains. CONCLUSIONS AND RELEVANCE: Cognitive impairment is common in patients with HNC and is associated with QoL and psychosocial variables. Together with previous research indicating that cognitive function and QoL can influence treatment adherence and outcomes, the results argue for the incorporation of cognitive screening and QoL assessment as part of pretreatment assessment for patients. QUESTION: What are the associations between cognitive functioning and quality of life (QoL) in patients prior to treatment for head and neck cancer within a multidisciplinary care team? FINDINGS: In this case series of 83 adults evaluated before head and neck cancer treatment, 46 (55%) had cognitive impairment. The number of depressive symptoms was associated with impairments in delayed recall and QoL; cognitive impairment and delayed recall were associated with lower QoL; and past substance use was associated with current QoL and cognitive function. MEANING: Cognitive impairment is common in patients with head and neck cancer and is associated with QoL and psychosocial variables. This case series investigates the associations between cognitive function and quality of life in patients prior to treatment for head and neck cancer.
引用
- Williams AM, Lindholm J, Cook D, et al. Association Between Cognitive Function and Quality of Life in Patients With Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2017. PMID: 29121151. doi:10.1001/jamaoto.2017.2014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。